Goldman Puts Waldron on Board, Tightening Succession Frame

Goldman Sachs named its president and chief operating officer John Waldron to its board of directors, Banking Dive reported on Feb. 27, 2025.

David Solomon is Chairman and Chief Executive Officer, according to Goldman Sachs. Waldron is president. The hierarchy is explicit. One chair-CEO. One president-COO.

Board membership changes the legal position. A director votes. A director owes fiduciary duties. A director sits with independent directors in executive session and in committee work, not only in operating reviews.

That governance change builds on earlier framing. The Wall Street Journal published an article titled "Goldman Sachs Is at War With Itself" on June 13, 2023. That reporting identified Waldron as Goldman's president and Solomon's second in command. It described Waldron as "considered a top contender."

The 2025 board appointment is the authoritative record on composition. The 2023 description is context. It does not compete on current status.

The broader context here is how large banks manufacture succession optionality without pre-committing. A sitting president and chief operating officer on the board gives independent directors sustained observation. Judgment under stress, capital allocation discipline, communication with regulators and large clients, all become directly observable over quarters. No search mandate is required. No timetable is disclosed.

In my view, the structure also tightens the information loop at the top. A president-COO with a board seat has formal access to board materials, minutes and deliberation. That reduces asymmetry between the chair-CEO and the No. 2. Continuity improves. The trade-off is familiar. The No. 2 now sits on both sides of the management-board line. For practitioners, the test is independence in practice: the frequency and candor of executive sessions without management present, committee composition, and whether the board preserves an external benchmark for the top role even while an internal candidate is in the room.

Looking at what this means for governance risk, the appointment narrows but does not resolve the duality question. A combined chair-CEO with a president-COO on the board concentrates operating and boardroom influence among two officers. Continuity risk falls. Concentration risk persists. Institutional counterparties often read a board-level No. 2 as lower transition friction. Proxy advisers and supervisors often ask a different question: whether the board retains credible capacity to run an open process, including external candidates, if conditions change.

For a bank holding company, that capacity is procedural. Charters, succession plans, evaluation criteria and recusal norms matter more than titles. A board seat does not designate a successor. It does give the board longer exposure, better information and fewer excuses if a transition becomes necessary. That is the narrow but material content of the February 2025 disclosure when read alongside the earlier Journal characterization.